Eddingpharm
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A commercial-stage oncology company bringing innovative cancer therapies to the Chinese market.
Oncology
Technology Platform
Focus on in-licensing and developing novel oncology therapeutics, with expertise in clinical development and commercialization in China.
Opportunities
Significant unmet medical need and rapid market expansion for innovative cancer drugs in China.
Risk Factors
Dependence on in-licensing deals and intensifying pricing pressure from national reimbursement negotiations.
Competitive Landscape
Faces competition from large domestic pharma and multinational corporations in the crowded but high-growth Chinese oncology market.